★
Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads: coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

Guided View
New to markets (prices, yields, YTD, market cap)? We explain every term as you browse, in plain English. Same data, with the help built in.

Expert View
You already know the market. Just the data: clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

RLMD

Relmada Therapeutics, Inc. · Healthcare · Biotechnology

3.29 +2.5% mkt cap $350.94M quote delayed (FMP) · as of Oct 22 22:08 UTC · separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
35Tracked holders
+5Δ holders
26.87MShares held
$129.62MReported value
+5New positions
−0Exits
Strongly Rising Conviction score 83/100 4 quarters of rising tracked shares ●●●●○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +16.7% · share flow +30.0% · net new positions +14.3% · formula
Broad accumulation: rising shares across more holders

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 52 +17 37.42M $258.91M +22 −5
Q1 2026 36 +1 37.39M $260.09M +3 −2
Q4 2025 35 +5 26.87M $129.62M +5 n/a
Q3 2025 8 0 1.94M $3.90M n/a n/a
Q2 2025 7 +1 1.68M $1.01M +1 n/a
Q1 2025 4 0 703.26K $189,901 n/a n/a
Q4 2024 4 -3 701.66K $364,906 n/a −3
Q3 2024 6 0 1.19M $3.85M n/a n/a
Q2 2024 6 n/a 857.82K $2.57M n/a n/a
Holder count
Who holds it · Q4 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 Janus Henderson Group Plc 7.27M n/a $35.04M 0.0% n/c 1 SEC ↗
2 Adage Capital Partners ✦ 4.27M New $20.62M 0.0% New 1 SEC ↗
3 Marshall Wace ✦ 3.19M +1072.4% $15.41M 0.0% ▲ Add 3 SEC ↗ ×3
4 Ameriprise Financial Inc 1.92M n/a $9.27M 0.0% n/c 1 SEC ↗
5 Millennium Management ✦ 1.67M New $8.08M 0.0% New 1 SEC ↗
6 Corient Private Wealth LP 1.44M n/a $6.89M 0.0% n/c 1 SEC ↗ ×2
7 BlackRock ✦ (passive) 1.27M +149.5% $6.12M 0.0% ▲ Add 3 SEC ↗ ×3
8 The Vanguard Group ✦ (passive) 1.20M +187.5% $5.81M 0.0% ▲ Add 3 SEC ↗ ×3
9 Geode Capital Management ✦ (passive) 854.93K +188.6% $4.13M 0.0% ▲ Add 7 SEC ↗ ×2
10 Two Sigma Investments ✦ 572.84K +229.9% $2.77M 0.0% ▲ Add 7 SEC ↗
11 Balyasny Asset Management L.P. 547.85K n/a $2.65M 0.0% n/c 1 SEC ↗
12 Susquehanna International Group, Llp 385.94K n/a $1.86M 0.0% n/c 1 SEC ↗
13 State Street Global Advisors ✦ (passive) 320.82K +215.1% $1.55M 0.0% ▲ Add 5 SEC ↗
14 Jane Street Group, Llc 271.11K n/a $1.31M 0.0% n/c 1 SEC ↗ ×2
15 Deutsche Bank Ag\ 224.85K n/a $1.09M 0.0% n/c 1 SEC ↗
16 Point72 Asset Management ✦ 187.38K New $905,031 0.0% New 1 SEC ↗
17 Renaissance Technologies ✦ 185.00K +9.0% $893,550 0.0% ▲ Add 7 SEC ↗
18 Northern Trust Corp 165.45K n/a $799,138 0.0% n/c 1 SEC ↗
19 Qube Research & Technologies Ltd 155.53K n/a $751,205 0.0% n/c 1 SEC ↗
20 Goldman Sachs Group ✦ 145.00K New $700,350 0.0% New 1 SEC ↗
21 Squarepoint Ops LLC 138.23K n/a $667,665 0.0% n/c 1 SEC ↗
22 Sei Investments Co 98.97K n/a $478,001 0.0% n/c 1 SEC ↗
23 Morgan Stanley ✦ 62.36K +5901.6% $301,185 0.0% ▲ Add 2 SEC ↗ ×5
24 Barclays Plc 60.00K n/a $289,800 0.0% n/c 1 SEC ↗
25 LMR Partners LLP 55.60K n/a $268,548 0.0% n/c 1 SEC ↗
26 Charles Schwab Investment… 53.08K n/a $256,381 0.0% n/c 1 SEC ↗
27 UBS Group AG 41.47K n/a $200,290 0.0% n/c 1 SEC ↗ ×4
28 Citadel Advisors ✦ 28.06K New $135,544 0.0% New 1 SEC ↗
29 Bank Of America Corp /De/ 25.34K n/a $122,393 0.0% n/c 1 SEC ↗ ×2
30 Citigroup Inc 22.53K n/a $108,839 0.0% n/c 1 SEC ↗
31 Simplex Trading, Llc 18.61K n/a $89,891 0.0% n/c 1 SEC ↗
32 Lido Advisors, LLC 13.90K n/a $27,949 0.0% n/c 1 SEC ↗
33 Bnp Paribas Financial Markets 3.04K n/a $14,683 0.0% n/c 1 SEC ↗
34 Royal Bank Of Canada 2.04K n/a $10,000 0.0% n/c 1 SEC ↗
35 Osaic Holdings, Inc. 5 n/a $24 0.0% n/c 1 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.

New buyers

Adage Capital Partners $20.62M 0.0%
Millennium Management $8.08M 0.0%
Point72 Asset Management $905,031 0.0%
Goldman Sachs Group $700,350 0.0%
Citadel Advisors $135,544 0.0%

Exited

No tracked exits this quarter.

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 103 holders, 83.66M shares, $576.39M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

Sep 10 TRAVERSA SERGIO

Officer, Director · Chief Executive… · 100.00K sh @ 4.10 · $410,000

Sep 10 Shenouda Maged

Officer · Chief Financial… · 79.80K sh @ 4.25 · $339,150

Sep 09 TRAVERSA SERGIO

Officer, Director · Chief Executive… · 100.00K sh @ 4.18 · $418,000

Sep 09 Shenouda Maged

Officer · Chief Financial… · 120.20K sh @ 4.20 · $504,840

Open-market sales (S)

No open-market insider sales in our coverage window.

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Beneficial ownership
Aug 14 SC 13G/A: Squadron Capital Management LLC

View original SEC filing ↗

Jul 29 SC 13G: BlackRock, Inc.

View original SEC filing ↗

Jun 22 SC 13G: MILLENNIUM MANAGEMENT LLC

View original SEC filing ↗

Jun 09 SC 13G: Venrock Healthcare Capital Partners…

View original SEC filing ↗

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q4 2025 · Methodology · Get this via the API